Response to "Comment's on the Story of the Silent Killer, a History of Hypertension: Its Discovery, Diagnosis, Treatment, and Debate"

Affiliations

¹ Pulmonary & Critical Care Medicine, The University of Alabama at Birmingham, THT 422, 1720 2nd Avenue South, Birmingham, AL, 35249-0006, USA. jpkalehoff@uabmc.edu.
² Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, THT 422, 1720 2nd Avenue South, Birmingham, AL, 35249-0006, USA.

Comment

Jonathan Kalehoff et al. Curr Hypertens Rep. 2021.

. 2021 Feb 3;23(2):7.

doi: 10.1007/s11906-020-01123-4.

¹ Pulmonary & Critical Care Medicine, The University of Alabama at Birmingham, THT 422, 1720 2nd Avenue South, Birmingham, AL, 35249-0006, USA. jpkalehoff@uabmc.edu.
² Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, THT 422, 1720 2nd Avenue South, Birmingham, AL, 35249-0006, USA.

No abstract available

Comment on

The Story of the Silent Killer : A History of Hypertension: Its Discovery, Diagnosis, Treatment, and Debates.
Kalehoff JP, Oparil S. Kalehoff JP, et al. Curr Hypertens Rep. 2020 Aug 27;22(9):72. doi: 10.1007/s11906-020-01077-7. Curr Hypertens Rep. 2020. PMID: 32852612 Review.
Comments on the Story of the Silent Killer, a History of Hypertension: Its Discovery, Diagnosis, Treatment, and Debate.
Taghizadieh A, Mohammadinasab R. Taghizadieh A, et al. Curr Hypertens Rep. 2021 Feb 3;23(2):6. doi: 10.1007/s11906-020-01122-5. Curr Hypertens Rep. 2021. PMID: 33537854 No abstract available.